State-level high and new technology enterprise30% of the employees are engaged in innovation and R&D. Over 30% of the R&D team members possess master’s degree and 20% of them graduated from “211 project” universities.

Complete manpower structure: machinery, safety, software, hardware, structure…

Just the infusion series products are granted over 60 patents and the copyright for over 10 software applications.

China's first touchscreen-based smart infusion workstation. 

Power-driven anti-free-flow clamp, automatic/manual integrated slider, and adaptive peristaltic pump finger assembly, which lead the technology trends of the infusion field

China's first ambulatory DVT preventive pump

Innovation is just the beginning. 

Medcaptain develops in-depth cooperation with Peking University, Southeast University, Harvard University, Imperial College London, University of Groningen, and Monash University and their affiliated clinical hospitals. In addition, Medcaptain conducts lots of clinical researches and applies cutting-edge technologies of the medical treatment and health field into the products with innovative design. 

Medcaptain cooperates with famous universities and their affiliated clinical hospitals in and outside China. 

For the syringe pump whose syringe is manually installed, there is a certain mechanical clearance between the slider and syringe. During infusion of high-risk drugs like vasoactive drug, such a mechanical clearance will bring about great impacts on the patient, for example, obvious oxygen concentration fluctuation. This problem did not draw sufficient attention in clinical application at one time. Consequently, most of the similar products take no count of this problem. One day, I consulted an ICU expert of Peking Union Medical College Hospital and finally realized the significance of quickly reaching steady infusion state. From then on, I decided to solve this problem.

Afterwards, we came to Peking Union Medical College Hospital and spent one week in the ICU to communicate with experts and medical personnel continuously for seeking a possible solution. The professors of Peking Union Medical College Hospital decided to solve this problem with our team. We finally shortened the time for reaching steady infusion state after infusion start from 8 minutes to 1 minute by improving the hardware and software systems of the syringe pump and conducting repeated test and adjustment. This is a very valuable progress for clinical infusion safety. In addition, this jointly developed technology has been granted an international patent. Both our team and the expert team of Peking Union Medical College Hospital are delighted and encouraged. 


According to communication with many medical personnel and orthopedists, all of them mentioned that patients just receiving a large or medium-sized surgery and elderly patients are at high risk of suffering from deep vein thrombosis (DVT). This risk not only exists in the hospitalization period of a patient but also exists in a period of time after the patient is discharged from the hospital. Therefore, we decided to develop an ambulatory product for helping patients to prevent DVT.

The product is widely accepted by the market because many patients have the demand of DVT prevention, proving that our decision is right. Clinical demands are always the source of our product innovation. 


After the HP-80 infusion workstation was put into service, clinical users liked it very much, and the demand even exceeded supply at one time. Even so, what we care about most was still whether the product functions well. Our internal improvement team kept on carrying out test and organized dozens of employees who have rich experience in clinical care, sales, marketing, or customer service to try out the product. Based on the strictest requirements, these employees discovered problems and gave advices relating to the UI, performance, and so on. Afterwards, we selected over 100 advices from all the over 300 advices for verification and finally conducted improvement for 10 key points.

We believe that no totally perfect product exists in the world. As long as a demand has value for clinical users, we always try our best to meet the demand and to build a product that is the most suitable for users and is the closest to a perfect product. 


The motion model of an assembly that looks simple may be very complex. To find an optimal balance between the sensitivity of an assembly and the impact on other assemblies, we performed test again and again, which took half an year. In addition, we improved the hand parts of the product five times, which cost a lot each time. Finally, we successfully developed a syringe pump that is the only syringe pump supporting 2 ml syringe in the industry.

Innovation is absolutely not unconstrained. At the back of each amazing performance, innovation is indeed very tough. We need to identify which parts require our efforts, find a correct method, and perform test continually. However, all these are worthwhile.